• PDX1 Mutation and m6A Methylation in Primate Pancreatic Agen

  2026-07-23

  Zhang et al. present the first CRISPR/Cas9-generated PDX1-mutant cynomolgus macaque model of MODY4, revealing a novel link between PDX1 haploinsufficiency, pancreatic agenesis, and altered m6A methylation. These findings clarify disease mechanisms previously inaccessible in rodent models and offer new targets for diabetes research.

• Verapamil HCl Targets Txnip to Modulate Osteoporosis Pathway

  2026-07-23

  This study reveals that verapamil, an established L-type calcium channel blocker, mitigates osteoporosis by targeting Txnip and modulating bone turnover in preclinical models. These findings provide mechanistic insight into verapamil’s actions on osteoclast and osteoblast signaling and highlight translational potential for managing postmenopausal osteoporosis.

• Protease Inhibitor Cocktail EDTA-Free: Optimizing Protein Ex

  2026-07-22

  Unlock high-fidelity protein analysis with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), designed for maximal compatibility with phosphorylation and enzyme assays. This guide details hands-on workflows, troubleshooting, and novel insights from recent oocyte maturation research to elevate your proteomics results.

• Toremifene: Selective Estrogen-Receptor Modulator in Prostat

  2026-07-22

  Toremifene empowers researchers to dissect estrogen receptor signaling and calcium pathways in advanced prostate cancer models. This guide translates high-impact findings—like the TSPAN18–STIM1 axis—into actionable experimental workflows, protocol enhancements, and troubleshooting solutions for hormone-responsive cancer research.

• Benzyl-Activated Streptavidin Magnetic Beads: Optimizing Ear

  2026-07-21

  Explore how Benzyl-activated Streptavidin Magnetic Beads enable highly specific, efficient detection of early cell death and streamline advanced molecular assays. This article offers unique scientific insights into biotinylated molecule capture, bridging molecular mechanisms with practical protocol guidance.

• Neuroligin 1 Loss in Striatal D2 Neurons Drives Repetitive B

  2026-07-21

  This study establishes a direct mechanistic link between Neuroligin 1 deficiency in striatal D2 receptor-expressing medium spiny neurons and the emergence of autistic-like repetitive behaviors in mice. Single-nucleus transcriptomics reveal PKC overactivation as a molecular driver, providing actionable insight for targeted intervention studies.

• Adefovir (GS-0393): Mechanism-Driven Strategy for Translatio

  2026-07-20

  This article provides a comprehensive roadmap for translational researchers leveraging Adefovir (GS-0393) in hepatitis B virus (HBV) and renal transporter studies. By dissecting mechanistic, pharmacokinetic, and workflow evidence, we outline how to optimize assay design, interpret clinical relevance, and maximize reproducibility using APExBIO’s high-purity Adefovir. Drawing on recent population PK data and cross-domain guidance, we highlight best practices and emerging frontiers in antiviral drug discovery.

• Bufalin–CRISPR Nanomedicine Induces Pyroptosis in CRC Immuno

  2026-07-20

  A recent study developed a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 ribonucleoprotein to target colorectal cancer. This approach synergistically induces pyroptosis and apoptosis in tumor cells while reprogramming the immune microenvironment, offering a promising strategy for improving immunotherapy outcomes.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-07-19

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide targeted capture and rapid magnetic separation of biotinylated molecules from complex samples, addressing specificity and workflow efficiency in protein, nucleic acid, and cell-based assays. These beads are not suitable for applications requiring covalent capture of non-biotinylated targets or where ultra-high yield outweighs the need for minimized background.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-07-18

  This article reviews a Nature Chemistry study that leverages native top-down mass spectrometry to directly characterize proteoform-specific interactions of membrane proteins within their native lipid environments. The findings provide pivotal insights into how post-translational modifications affect drug specificity and off-target binding, with implications for rational drug design targeting complex signaling pathways.

• Docetaxel in Cancer Chemotherapy Research: Applied Workflows

  2026-07-17

  Docetaxel (Taxotere) stands at the frontier of cancer chemotherapy research, enabling precise modeling of apoptosis and chemoresistance in both in vitro and in vivo systems. This article deciphers experimental workflows, troubleshooting strategies, and unique comparative advantages, empowering researchers to maximize reproducibility and translational impact when leveraging Docetaxel from APExBIO.

• Thiazovivin (A5506): Practical Guide for Stem Cell Workflows

  2026-07-17

  Thiazovivin is a high-purity ROCK inhibitor used to improve the efficiency of induced pluripotent stem cell generation and human embryonic stem cell survival during stressful manipulations. It is suited for workflows requiring enhanced cell viability or reprogramming, but is not intended for diagnostic or therapeutic applications.

• Resibufogenin Inhibits NLRP3 Inflammasome to Protect Against

  2026-07-16

  Chen et al. reveal that resibufogenin (RBG) directly inhibits NLRP3 inflammasome assembly, reducing inflammation and atherosclerotic plaque formation in ApoE-/- mice. Their work highlights a novel anti-inflammatory mechanism and suggests RBG as a candidate for targeted cardiovascular therapy.

• Betaine Hydrochloride in Metabolic Enzyme & Protease Assays

  2026-07-16

  Betaine hydrochloride (carboxymethyl(trimethyl)azanium chloride) is an indispensable reagent for metabolic enzyme and protease research, enabling high-precision workflows and reproducibility. Its unique solubility and high purity make it a preferred choice for advanced biochemical and molecular biology applications.

• DiD (DiDC 18 (5)) in Advanced Membrane Labeling Workflows

  2026-07-15

  DiD (DiDC 18 (5)) redefines plasma membrane staining and cell tracking in high-autofluorescence, inflammation, and immunofluorescence-compatible assays. Its robust diffusion and long-wavelength emission enable reproducible, high-contrast visualization for demanding applications such as neuronal tracing and chronic disease modeling.

8633 records 5/576 page Previous Next 12345 下5页 Last page